BOSTON, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical- As the U.S. stock market experiences a rally led by the technology sector, investors are closely ...
D. Boral Capital has recently initiated Compass Therapeutics Inc. (CMPX) stock to Buy rating, as announced on December 23, 2024, according to Finviz. Earlier, on November 15, 2024, Leerink Partners ...
On Thursday, Compass Inc (COMP) stock saw a modest uptick, ending the day at $6.73 which represents a slight increase of $0.07 or 1.05% from the prior close of $6.66. The stock opened at $6.64 and ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...